Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Our Vision

Our vision is to transform research and healthcare in dementia. Dementia Research Oxford, led by Professors Masud Husain and Cornelia van Duijn, brings together researchers and clinicians across the University, our hospitals, patients and industry partners to translate our growing insights in the basic molecular origin disease into effective treatment and prevention. We aim to take science further from drug target to treatment, from molecular pathology to early diagnosis and prognosis and from early intervention to prevention

From drug target to treatment

Combining our powerful chemistry with PET imaging provides the potential to monitor how drugs interact with their targets in the brain to improve development of new therapies

From molecular pathology to early diagnosis and prognosis

Using state of the art molecular research and big data analysis allows us to improve the early diagnosis and monitor the disease process long before the dementia.

From early intervention to prevention

Using our renowned clinical trial centre and world class clinical and preventive trial expertise, we aim move new potential drugs and life style interventions to the clinic and curb the current epidemic of dementia.

Our Dementia Research Oxford Teams